Prochlorperazine: Difference between revisions
(special poulations) |
(serious reactions) |
||
| Line 44: | Line 44: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*tardive dyskinesia | |||
*neuroleptic malignant syndrome | |||
*blood dyscrasias | |||
*agranulocytosis | |||
*leukopenia | |||
*neutropenia | |||
*hemolytic anemia | |||
* | |||
===Common=== | ===Common=== | ||
Revision as of 08:33, 5 February 2016
General
- Type: anti-psychotic and anti-emetic
- Dosage Forms: 5, 10
- Routes of Administration: IV, PO
- Common Trade Names: Compazine
Adult Dosing
Headache
- 10 mg IV (slow push or in 1L IV NS)
Nausea/Vomiting
- 5-10 mg PO or IV q6-8 hours
- Max: 40mg/day
Pediatric Dosing
nausea/vomiting, severe
2 yo and older, 9-14 kg
- 2.5 mg PO q12-24 h; Max 7.5 mg/day
2 yo and older, 14-18 kg
- 2.5 mg PO q8-12 h; Max 10 mg/day
2 yo and older, 18-39 kg
- 2.5 mg PO q8 hr; Max 15 mg/day
2 yo and older, >39 kg
- 5 mg PO q6-8 h, Max: 20 mg/day
Schizophrenia
2-5 yo
- 2.5 - 5 mg PO q6-8 hr, Max 20 mg/day
6-12 yo
- 2.5-5 mg PO q6-8 hr, Max 25 mg/day
Special Populations
- Pregnancy Rating: Pregnancy category C
- Lactation risk: Safety unknown
- Renal Dosing: not defined
- Hepatic Dosing: not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- tardive dyskinesia
- neuroleptic malignant syndrome
- blood dyscrasias
- agranulocytosis
- leukopenia
- neutropenia
- hemolytic anemia
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
